Optimal Two-Stage Phase II Design Biomarker Targeted Randomized Design Targeted design randomizes only marker positive patients to treatment or control arm. Untargeted design does not measure marker and randomizes all who otherwise are eligible. Biomarker Stratified Randomized Design Stratified design randomizes both marker positive and negative patients. Sample Size Planning for Developing Classifiers Using High Dimensional Data

© NIH, 2007